Compounds of Formulae (I), (II) and (III), including pharmaceutically acceptable salts are described herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions a disease or disorder that can be treated with a KOR agonist and/or MOR agonist. Compounds described herein, along with pharmaceutically acceptable salts and compositions thereof, can be used to alleviate at least one symptom of the disease or disorder described herein.
Diastereoselective synthesis of β-lactams via Kinugasa reaction of acyclic chiral nitrones
摘要:
An approach to beta-lactams via a Kinugasa reaction between chiral copper acetylides and chiral acyclic nitrones bearing either 1,3-dioxane or 1,3-dioxolane moieties is reported. The stereochemical preferences observed in these reactions are discussed. The reaction provides access to a variety of interesting beta-lactam structures. Electronic circular dichroism in combination with NMR spectroscopy was shown to be a useful and effective method for the reliable determination of the absolute configuration of all components of a complex mixtures of azetidinones. The effectiveness of the chiral analysis of complex mixtures was demonstrated for HPLC coupled on-line with electronic circular dichroism detection as well. (C) 2015 Elsevier Ltd. All rights reserved.
[EN] A PROCESS FOR THE PREPARATION OF AN ALDEHYDE BETA-LACTAM COMPOUND<br/>[FR] PROCÉDÉ DE PRÉPARATION D'UN COMPOSÉ BÊTA-LACTAME D'ALDÉHYDE
申请人:ADAMED SP ZOO
公开号:WO2010097350A1
公开(公告)日:2010-09-02
The invention relates to a process for the preparation of an aldehyde beta-lactam compound of formula (I), wherein P1 is H or a protecting group, useful in the preparation of ezetimibe, from a nitrone compound of formula (II). The nitrone compound Il is prepared by reacting 4-fluorophenylhydroxyloamine with OH- protected 4-hydroxybenzaldehyde. The nitrone compound of formula (II) is reacted with an acetylene compound of formula (III) to form a compound of formula (IV), and the compound of formula (IV), after optional deprotection, is oxidized to obtain an aldehyde of formula (V), which undergoes isomerisation to the compound of formula (I). The subject of the invention are also novel compounds of formulas (II) and (IV).
entry toward thienamycin and related compounds. The copper(I)-mediated reaction between five-membered cyclic nitrones and terminal acetylenes, leading to the assembly of the basic skeleton of carbapenemantibiotics is described. The diastereoselectivity of this cycloaddition–rearrangement cascade, a process known as the Kinugasa reaction, with respect to the structure and configuration of both substrates
Total synthesis of both enantiomers of melodorinol. Redetermination of their absolute configurations
作者:Xiyan Lu、Guoying Chen、Lijun Xia、Guangzhong Guo
DOI:10.1016/s0957-4166(97)00373-x
日期:1997.9
Both enantiomers of the natural products, melodorinol and acetylmelodorinol, have been synthesized by a palladium catalyzed enyne coupling methodology. Their absoluteconfiguration aare redetermined.
shifts of the H-2 proton and geminal protons of the protected alkoxymethyl group at the C-2 carbon atom. The differences of 1 H NMR chemical shifts of these protons fall in two ranges of about 3.3-3.7 ppm, and 4.0-4.4 ppm. This observation can be attributed to the influence of the anisotropy of the neighboring carbonylgroup and can be easily correlated with configuration at the bridgehead carbon atom
First application of fluorinated nitrones for the synthesis of fluoroalkylated β-lactams via the Kinugasa reaction
作者:Marcin K. Kowalski、Grzegorz Mlostoń、Emilia Obijalska、Anthony Linden、Heinz Heimgartner
DOI:10.1016/j.tet.2016.06.073
日期:2016.9
The regioselective reactions of fluorinated nitrones with selected terminal alkynes (Kinugasareaction) was studied in the presence of Cu(I) iodide and TEA as a base. After chromatographic purification the desired β-lactams were obtained in high yields (up to 93%) and high diastereoselectivities (up to 9:1). The reactions performed in the presence of chiral, enantiomerically pure ligands led to enantiomerically